LGND icon

Ligand Pharmaceuticals
LGND

Overview Fund Activity

206 hedge funds and large institutions have $2.28B invested in Ligand Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 73 increasing their positions, 71 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
206
Holders Change
-5
Holders Change %
-2.37%
% of All Funds
3.62%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
18
Increased
73
Reduced
71
Closed
23
Calls
$26.6M
Puts
$8.4M
Net Calls
+$18.1M
Net Calls Change
-$2M

Top Buyers

1
BlackRock
BlackRock
New York
+$95.7M
2
CCMLC
Cardinal Capital Management LLC (Connecticut)
Connecticut
+$29.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$27.6M
4
William Blair Investment Management
William Blair Investment Management
Illinois
+$18M
5
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Illinois
+$9.59M

Top Sellers

1
CCA
Conestoga Capital Advisors
Pennsylvania
-$57.8M
2
Millennium Management
Millennium Management
New York
-$14.2M
3
Federated Hermes
Federated Hermes
Pennsylvania
-$7.83M
4
Aberdeen Group
Aberdeen Group
United Kingdom
-$6.63M
5
Northern Trust
Northern Trust
Illinois
-$6.51M
Name Holding Trade Value Shares
Change 		Shares
Change %
WT
226
Whittier Trust
California
– -$3K -32 Closed
WPA
227
West Paces Advisors
Georgia
– -$2.23K -27 Closed
EFSCE
228
Enterprise Financial Services Corp (EFSC)
Missouri
– -$2K -21 Closed
6 7 8 9
10